Bridgeway Capital Management’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,000
Closed -$21.3K 1443
2023
Q2
$21.3K Sell
5,000
-2,470
-33% -$14K ﹤0.01% 1362
2023
Q1
$42.1K Sell
7,470
-3,780
-34% -$28.7K ﹤0.01% 1323
2022
Q4
$93.4K Buy
+11,250
New +$220K ﹤0.01% 1229

Other funds holding SNCE

Bridgeway Capital Management's SNCE Position: Q3 2023 in Review

Bridgeway Capital Management sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q3 2023, closing a stake of 5,000 shares — an estimated $21.3K sold.

Bridgeway Capital Management first reported a position in SNCE in Q4 2022 and held it in 3 quarters. The position peaked at $93.4K in Q4 2022. 43 funds tracked by Wall St. Rank hold SNCE as of Q3 2023.

  • Bridgeway Capital Management reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 5,000 Science 37 Holdings, Inc. Common Stock shares in Q3 2023, an estimated $21.3K.
  • Bridgeway Capital Management first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Bridgeway Capital Management's Science 37 Holdings, Inc. Common Stock position peaked at $93.4K in Q4 2022.
  • 43 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.